GelStat Corporation (GSAC) 是一家上市公司 屬於 醫療保健 板塊,經營於 制药 - 专科与仿制药 產業. 公司總部位於 Palm City, FL, 美国. 現任CEO為 Javier G. Acosta.
GSAC 擁有 IPO日期為 1996-02-09, 2 名全職員工, 在 Other OTC, 市值為 $185.39K.
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation is headquartered in Palm City, Florida.